Northstar Asset Management LLC lowered its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 2.8% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 28,507 shares of the medical research company’s stock after selling 834 shares during the period. Thermo Fisher Scientific comprises about 3.3% of Northstar Asset Management LLC’s investment portfolio, making the stock its 6th biggest holding. Northstar Asset Management LLC’s holdings in Thermo Fisher Scientific were worth $8,372,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Private Trust Co. NA increased its stake in shares of Thermo Fisher Scientific by 66.7% during the second quarter. Private Trust Co. NA now owns 3,273 shares of the medical research company’s stock valued at $961,000 after acquiring an additional 1,310 shares during the period. Parallel Advisors LLC increased its stake in shares of Thermo Fisher Scientific by 4.4% during the first quarter. Parallel Advisors LLC now owns 9,416 shares of the medical research company’s stock valued at $2,578,000 after acquiring an additional 393 shares during the period. Barrett Asset Management LLC increased its stake in shares of Thermo Fisher Scientific by 0.4% during the first quarter. Barrett Asset Management LLC now owns 111,500 shares of the medical research company’s stock valued at $30,520,000 after acquiring an additional 395 shares during the period. CX Institutional acquired a new position in shares of Thermo Fisher Scientific during the first quarter valued at approximately $36,000. Finally, Highstreet Asset Management Inc. acquired a new position in shares of Thermo Fisher Scientific during the first quarter valued at approximately $381,000. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,713 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, April 30th. The shares were sold at an average price of $273.21, for a total transaction of $13,855,298.73. Following the transaction, the chief executive officer now directly owns 302,193 shares in the company, valued at approximately $82,562,149.53. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director C Martin Harris sold 275 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $270.73, for a total transaction of $74,450.75. Following the transaction, the director now owns 6,433 shares in the company, valued at $1,741,606.09. The disclosure for this sale can be found here. In the last 90 days, insiders sold 53,488 shares of company stock worth $14,600,474. 0.45% of the stock is currently owned by company insiders.

Thermo Fisher Scientific stock opened at $287.21 on Friday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.16 and a current ratio of 1.49. The firm has a market capitalization of $114.88 billion, a price-to-earnings ratio of 24.51, a price-to-earnings-growth ratio of 1.88 and a beta of 1.10. Thermo Fisher Scientific Inc. has a 1 year low of $208.34 and a 1 year high of $305.45. The business has a 50 day simple moving average of $291.39.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Wednesday, July 24th. The medical research company reported $3.04 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.01 by $0.03. The firm had revenue of $6.32 billion for the quarter, compared to analyst estimates of $6.31 billion. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.75 earnings per share. Analysts predict that Thermo Fisher Scientific Inc. will post 12.23 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, September 17th will be given a $0.19 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $0.76 annualized dividend and a yield of 0.26%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 6.83%.

A number of research analysts recently commented on TMO shares. Needham & Company LLC raised their price objective on shares of Thermo Fisher Scientific from $315.00 to $321.00 and gave the company a “buy” rating in a research note on Thursday. UBS Group lowered shares of AGL Energy to a “sell” rating in a research note on Thursday, May 23rd. Bank of America lowered shares of Propetro from a “buy” rating to a “neutral” rating in a research note on Tuesday, April 16th. Wolfe Research started coverage on shares of Waters in a research note on Thursday, May 30th. They set an “underperform” rating on the stock. Finally, Argus raised their price objective on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $302.55.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Recommended Story: Stop Order

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.